Jeremy Pettus

Title(s)Associate Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse Websites

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial. Diabetes Care. 2024 May 22. Boeder SC, Thomas RL, Le Roux MJ, Giovannetti ER, Gregory JM, Pettus JH. PMID: 38776437.
      View in: PubMed   Mentions:    Fields:    
    2. Continuous positive airway pressure is here to stay. Lancet Respir Med. 2024 May 17. Malhotra A, Pettus JH. PMID: 38768623.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin. Diabetes Technol Ther. 2024 May 13. Boeder S, Davies MJ, McGill JB, Pratley R, Girard M, Banks P, Pettus J, Garg S. PMID: 38441906.
      View in: PubMed   Mentions:    Fields:    
    4. Time in Tight Range for Patients With Type 1 Diabetes: The Time Is Now, or Is It Too Soon? Diabetes Care. 2024 May 01; 47(5):782-784. Hamidi V, Pettus JH. PMID: 38640413.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes. Diabetes Care. 2024 May 01; 47(5):e39-e41. Thomas RL, Boeder SC, Hamidi V, Giovannetti ER, Gregory JM, Pettus JH. PMID: 38394365; PMCID: PMC11043219.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Repositioning the Early Pathology of Type 1 Diabetes to the Extraislet Vasculature. J Immunol. 2024 Apr 01; 212(7):1094-1104. Costanzo A, Clarke D, Holt M, Sharma S, Nagy K, Tan X, Kain L, Abe B, Luce S, Boitard C, Wyseure T, Mosnier LO, Su AI, Grimes C, Finn MG, Savage PB, Gottschalk M, Pettus J, Teyton L. PMID: 38426888; PMCID: PMC10944819.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    7. Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-Sectional Survey. Diabetes Care. 2024 Jan 31. Sherr JL, Laffel LM, Liu J, Wolf W, Bispham J, Chapman KS, Finan D, Titievsky L, Liu T, Hagan K, Gaglia J, Chandarana K, Bergenstal R, Pettus J. PMID: 38295397.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Reflecting on a Year at the Helm of Diabetes Care. Diabetes Care. 2024 Jan 01; 47(1):4-6. Kahn SE, Anderson CAM, Buse JB, Selvin E, Angell SY, Aroda VR, Cheng AYY, Danne T, Echouffo-Tcheugui JB, Fitzpatrick SL, Gadgil MD, Gastaldelli A, Gloyn AL, Green JB, Jastreboff AM, Kanaya AM, Kandula NR, Kovesdy CP, Laiteerapong N, Nadeau KJ, Pettus J, Pop-Busui R, Posey JE, Powe CE, Rebholz CM, Rickels MR, Sattar N, Shaw JE, Sims EK, Utzschneider KM, Vella A, Zhang C. PMID: 38117988.
      View in: PubMed   Mentions:    Fields:    
    9. Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nat Med. 2023 Nov; 29(11):2959. Pettus J, Boeder SC, Christiansen MP, Denham DS, Bailey TS, Akturk HK, Klaff LJ, Rosenstock J, Cheng MHM, Bode BW, Bautista ED, Xu R, Yan H, Thai D, Garg SK, Klein S. PMID: 36932248.
      View in: PubMed   Mentions:    Fields:    
    10. Measuring anti-islet autoimmunity in mouse and human by profiling peripheral blood antigen-specific CD4 T cells. Sci Transl Med. 2023 07 05; 15(703):eade3614. Sharma S, Tan X, Boyer J, Clarke D, Costanzo A, Abe B, Kain L, Holt M, Armstrong A, Rihanek M, Su A, Speake C, Gottlieb P, Gottschalk M, Pettus J, Teyton L. PMID: 37406136; PMCID: PMC10495123.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    11. Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia. Diabetes Obes Metab. 2023 07; 25(7):1985-1994. Ciaraldi TP, Boeder SC, Mudaliar SR, Giovannetti ER, Henry RR, Pettus JH. PMID: 36999233; PMCID: PMC10740106.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    12. CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes. Cardiovasc Diabetol. 2023 03 16; 22(1):59. Schnell O, Battelino T, Bergenstal R, Birkenfeld AL, Ceriello A, Cheng A, Davies M, Edelman S, Forst T, Giorgino F, Green J, Groop PH, Hadjadj S, J L Heerspink H, Hompesch M, Izthak B, Ji L, Kanumilli N, Mankovsky B, Mathieu C, Miszon M, Mustafa R, Nauck M, Pecoits-Filho R, Pettus J, Ranta K, Rodbard HW, Rossing P, Ryden L, Schumm-Draeger PM, Solomon SD, Škrha J, Topsever P, Vilsbøll T, Wilding J, Standl E. PMID: 36927451; PMCID: PMC10019427.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nat Med. 2022 10; 28(10):2092-2099. Pettus J, Boeder SC, Christiansen MP, Denham DS, Bailey TS, Akturk HK, Klaff LJ, Rosenstock J, Cheng MHM, Bode BW, Bautista ED, Xu R, Yan H, Thai D, Garg SK, Klein S. PMID: 36192552; PMCID: PMC9872851.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    14. A Multicenter Randomized Trial Evaluating the Insulin-Only Configuration of the Bionic Pancreas in Adults with Type 1 Diabetes. Diabetes Technol Ther. 2022 10; 24(10):697-711. Kruger D, Kass A, Lonier J, Pettus J, Raskin P, Salam M, Trikudanathan S, Zhou K, Russell SJ, Damiano ER, El-Khatib FH, Ruedy KJ, Balliro C, Li Z, Marak MC, Calhoun P, Beck RW. PMID: 36173236; PMCID: PMC9634987.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    15. Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. N Engl J Med. 2022 09 29; 387(13):1161-1172. Bionic Pancreas Research Group, Russell SJ, Beck RW, Damiano ER, El-Khatib FH, Ruedy KJ, Balliro CA, Li Z, Calhoun P, Wadwa RP, Buckingham B, Zhou K, Daniels M, Raskin P, White PC, Lynch J, Pettus J, Hirsch IB, Goland R, Buse JB, Kruger D, Mauras N, Muir A, McGill JB, Cogen F, Weissberg-Benchell J, Sherwood JS, Castellanos LE, Hillard MA, Tuffaha M, Putman MS, Sands MY, Forlenza G, Slover R, Messer LH, Cobry E, Shah VN, Polsky S, Lal R, Ekhlaspour L, Hughes MS, Basina M, Hatipoglu B, Olansky L, Bhangoo A, Forghani N, Kashmiri H, Sutton F, Choudhary A, Penn J, Jafri R, Rayas M, Escaname E, Kerr C, Favela-Prezas R, Boeder S, Trikudanathan S, Williams KM, Leibel N, Kirkman MS, Bergamo K, Klein KR, Dostou JM, Machineni S, Young LA, Diner JC, Bhan A, Jones JK, Benson M, Bird K, Englert K, Permuy J, Cossen K, Felner E, Salam M, Silverstein JM, Adamson S, Cedeno A, Meighan S, Dauber A. PMID: 36170500; PMCID: PMC10028490.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    16. Impact of the hepatoselective glucokinase activator TTP399 on ketoacidosis during insulin withdrawal in people with type 1 diabetes. Diabetes Obes Metab. 2022 08; 24(8):1439-1447. Klein KR, Boeder SC, Freeman JLR, Dunn I, Dvergsten C, Madduri S, Giovannetti ER, Valcarce C, Buse JB, Pettus JH. PMID: 35661378; PMCID: PMC9262835.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. Erratum. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532. Diabetes Care. 2022 May 01; 45(5):1299. Gregory JM, Slaughter JC, Duffus SH, Smith TJ, LeStourgeon LM, Jaser SS, McCoy AB, Luther JM, Giovannetti ER, Boeder S, Pettus JH, Moore DJ. PMID: 35235947; PMCID: PMC9174957.
      View in: PubMed   Mentions:    Fields:    
    18. SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants With Type 1 Diabetes. Diabetes. 2022 03 01; 71(3):511-519. Boeder SC, Gregory JM, Giovannetti ER, Pettus JH. PMID: 34857545; PMCID: PMC8893946.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. Risk of new-onset type 2 diabetes in 600 055 people after COVID-19: A cohort study. Diabetes Obes Metab. 2022 06; 24(6):1176-1179. Birabaharan M, Kaelber DC, Pettus JH, Smith DM. PMID: 35112782; PMCID: PMC9035030.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    20. Correction to: The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2022 Jan; 65(1):255. Holt RIG, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, Klupa T, Ludwig B, Nørgaard K, Pettus J, Renard E, Skyler JS, Snoek FJ, Weinstock RS, Peters AL. PMID: 34851428; PMCID: PMC8895052.
      View in: PubMed   Mentions: 4     Fields:    
    21. Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device. Cell Rep Med. 2021 12 21; 2(12):100466. Shapiro AMJ, Thompson D, Donner TW, Bellin MD, Hsueh W, Pettus J, Wilensky J, Daniels M, Wang RM, Brandon EP, Jaiman MS, Kroon EJ, D'Amour KA, Foyt HL. PMID: 35028608; PMCID: PMC8714853.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCellsCTClinical Trials
    22. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021 12; 64(12):2609-2652. Holt RIG, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, Klupa T, Ludwig B, Nørgaard K, Pettus J, Renard E, Skyler JS, Snoek FJ, Weinstock RS, Peters AL. PMID: 34590174; PMCID: PMC8481000.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    23. Importance of diabetes management during the COVID-19 pandemic. Postgrad Med. 2021 Nov; 133(8):912-919. Pettus J, Skolnik N. PMID: 34602003.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    24. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021 11; 44(11):2589-2625. Holt RIG, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, Klupa T, Ludwig B, Nørgaard K, Pettus J, Renard E, Skyler JS, Snoek FJ, Weinstock RS, Peters AL. PMID: 34593612.
      View in: PubMed   Mentions: 107     Fields:    Translation:Humans
    25. Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532. Diabetes Care. 2021 05; 44(5):e103-e104. Gregory JM, Slaughter JC, Duffus SH, Smith TJ, LeStourgeon LM, Jaser SS, McCoy AB, Luther JM, Giovannetti ER, Boeder S, Pettus JH, Moore DJ. PMID: 33972321; PMCID: PMC8132332.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    26. A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100. Diabetes Care. 2021 07; 44(7):1595-1603. Lingvay I, Buse JB, Franek E, Hansen MV, Koefoed MM, Mathieu C, Pettus J, Stachlewska K, Rosenstock J. PMID: 33875484; PMCID: PMC8323172.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    27. A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery System. Diabetes Technol Ther. 2021 05; 23(5):367-375. Lum JW, Bailey RJ, Barnes-Lomen V, Naranjo D, Hood KK, Lal RA, Arbiter B, Brown AS, DeSalvo DJ, Pettus J, Calhoun P, Beck RW. PMID: 33226840; PMCID: PMC8080906.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    28. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care. 2021 02; 44(2):526-532. Gregory JM, Slaughter JC, Duffus SH, Smith TJ, LeStourgeon LM, Jaser SS, McCoy AB, Luther JM, Giovannetti ER, Boeder S, Pettus JH, Moore DJ. PMID: 33268335; PMCID: PMC7818316.
      View in: PubMed   Mentions: 125     Fields:    Translation:Humans
    29. Utilizing continuous glucose monitoring in primary care practice: What the numbers mean. Prim Care Diabetes. 2021 04; 15(2):199-207. Edelman SV, Cavaiola TS, Boeder S, Pettus J. PMID: 33257275.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    30. Demographic characteristics and acute complications among adults with type 1 diabetes: Comparison of two multicentre databases from Germany and the United States. J Diabetes Complications. 2021 03; 35(3):107812. Eckert AJ, Zhou FL, Grimsmann JM, Pettus JH, Kerner W, Miller KM, Stechemesser L, Edelman SV, Spies C, Holl RW, Ibald-Mulli AM. PMID: 33280985.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort. Diabetes Res Clin Pract. 2020 Jul; 165:108235. Mather KJ, Bebu I, Baker C, Cohen RM, Crandall JP, DeSouza C, Green JB, Kirkman MS, Krause-Steinrauf H, Larkin M, Pettus J, Seaquist ER, Soliman EZ, Schroeder EB, Wexler DJ, Pop-Busui R, GRADE Research Group. PMID: 32450102; PMCID: PMC7416515.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    32. Estimation of Annual Health Care Costs for Adults with Type 1 Diabetes in the United States. J Manag Care Spec Pharm. 2020 Mar; 26(3):311-318. Joish VN, Zhou FL, Preblick R, Lin D, Deshpande M, Verma S, Davies MJ, Paranjape S, Pettus J. PMID: 32105172; PMCID: PMC10390990.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    33. Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real-world study of more than 30 000 patients in a US electronic health record database. Diabetes Obes Metab. 2020 04; 22(4):622-630. Pettus JH, Zhou FL, Shepherd L, Mercaldi K, Preblick R, Hunt PR, Paranjape S, Miller KM, Edelman SV. PMID: 31789439; PMCID: PMC7079022.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    34. Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes. JCI Insight. 2019 12 19; 4(24). Herold KC, Bucktrout SL, Wang X, Bode BW, Gitelman SE, Gottlieb PA, Hughes J, Joh T, McGill JB, Pettus JH, Potluri S, Schatz D, Shannon M, Udata C, Wong G, Levisetti M, Ganguly BJ, Garzone PD, RN168 Working Group. PMID: 31852846; PMCID: PMC6975260.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    35. Efficacy and Safety of the Glucagon Receptor Antagonist RVT-1502 in Type 2 Diabetes Uncontrolled on Metformin Monotherapy: A 12-Week Dose-Ranging Study. Diabetes Care. 2020 01; 43(1):161-168. Pettus JH, D'Alessio D, Frias JP, Vajda EG, Pipkin JD, Rosenstock J, Williamson G, Zangmeister MA, Zhi L, Marschke KB. PMID: 31694861.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    36. Single-Cell Analysis of CD4 T Cells in Type 1 Diabetes: From Mouse to Man, How to Perform Mechanistic Studies. Diabetes. 2019 10; 68(10):1886-1891. Sharma S, Pettus J, Gottschalk M, Abe B, Gottlieb P, Teyton L. PMID: 31540941; PMCID: PMC6754240.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    37. Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study. Diabetes Care. 2019 12; 42(12):2220-2227. Pettus JH, Zhou FL, Shepherd L, Preblick R, Hunt PR, Paranjape S, Miller KM, Edelman SV. PMID: 31548241.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    38. Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes. Diabetes Technol Ther. 2019 09; 21(9):471-477. Danne T, Pettus J, Giaccari A, Cariou B, Rodbard H, Weinzimer SA, Bonnemaire M, Sawhney S, Stewart J, Wang S, Castro RC, Garg SK. PMID: 31335194; PMCID: PMC6708262.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    39. Adjunct Therapy in Type 1 Diabetes: A Survey to Uncover Unmet Needs and Patient Preferences Beyond HbA1c Measures. Diabetes Technol Ther. 2019 06; 21(6):336-343. Pettus JH, Kushner JA, Valentine V, Wood R, Pang C, Paranjape S, Berria R, Deluzio A, Edelman SE. PMID: 31095422; PMCID: PMC6551969.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    40. Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring. Diabetes Obes Metab. 2019 08; 21(8):1906-1913. Pettus J, Gill J, Paranjape S, Stewart J, Malla S, Edelman S, Bergenstal RM, Bode B. PMID: 30993855.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    41. Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study. Diabetes Ther. 2019 Apr; 10(2):617-633. Pettus J, Roussel R, Liz Zhou F, Bosnyak Z, Westerbacka J, Berria R, Jimenez J, Eliasson B, Hramiak I, Bailey T, Meneghini L. PMID: 30767173; PMCID: PMC6437256.
      View in: PubMed   Mentions: 29  
    42. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors. Diabetes Care. 2019 Jun; 42(6):1147-1154. Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, Alexander CM, Battelino T, Ampudia-Blasco FJ, Bode BW, Cariou B, Close KL, Dandona P, Dutta S, Ferrannini E, Fourlanos S, Grunberger G, Heller SR, Henry RR, Kurian MJ, Kushner JA, Oron T, Parkin CG, Pieber TR, Rodbard HW, Schatz D, Skyler JS, Tamborlane WV, Yokote K, Phillip M. PMID: 30728224; PMCID: PMC6973545.
      View in: PubMed   Mentions: 101     Fields:    Translation:Humans
    43. Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes. Diabetes Obes Metab. 2019 04; 21(4):812-821. Cusi K, Bril F, Barb D, Polidori D, Sha S, Ghosh A, Farrell K, Sunny NE, Kalavalapalli S, Pettus J, Ciaraldi TP, Mudaliar S, Henry RR. PMID: 30447037.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    44. Stem cell therapies for Type 1 diabetes: current status and proposed road map to guide successful clinical trials. Diabet Med. 2019 03; 36(3):297-307. Senior PA, Pettus JH. PMID: 30362170.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    45. Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring. Diabetes Care. 2018 11; 41(11):2265-2274. Edelman SV, Argento NB, Pettus J, Hirsch IB. PMID: 30348844.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    46. Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Technol Ther. 2018 11; 20(11):715-724. Henry RR, Strange P, Zhou R, Pettus J, Shi L, Zhuplatov SB, Mansfield T, Klein D, Katz A. PMID: 30222367; PMCID: PMC6208164.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    47. Recommendations for Initiating Use of Afrezza Inhaled Insulin in Individuals with Type 1 Diabetes. Diabetes Technol Ther. 2018 06; 20(6):448-451. Pettus J, Santos Cavaiola T, Edelman SV. PMID: 29901406.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    48. Cardiovascular effects of sodium glucose cotransporter 2 inhibitors. Diabetes Metab Syndr Obes. 2018; 11:133-148. Cavaiola TS, Pettus J. PMID: 29695924; PMCID: PMC5905845.
      View in: PubMed   Mentions: 13  
    49. Fixed-ratio combination therapy for type 2 diabetes: the top ten things you should know about insulin and glucagon-like peptide-1 receptor agonist combinations. Postgrad Med. 2018 May; 130(4):375-380. Blumer I, Pettus JH, Santos Cavaiola T. PMID: 29521173.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    50. The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3. PLoS One. 2018; 13(1):e0190579. Yale JF, Pettus JH, Brito-Sanfiel M, Lavalle-Gonzalez F, Merino-Trigo A, Stella P, Chevalier S, Buzzetti R. PMID: 29370218; PMCID: PMC5784896.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trial. Diabetes Obes Metab. 2018 05; 20(5):1302-1305. Pettus J, Reeds D, Cavaiola TS, Boeder S, Levin M, Tobin G, Cava E, Thai D, Shi J, Yan H, Bautista E, McMillan J, Unger R, Henry RR, Klein S. PMID: 29283470; PMCID: PMC6181222.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    52. The shifting paradigm of a "cure" for type 1 diabetes: is technology replacing immune-based therapies? Acta Diabetol. 2018 Feb; 55(2):117-120. Pettus J, Von Herrath M. PMID: 29188386; PMCID: PMC5816711.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    53. Morning administration of 0.4U/kg/day insulin glargine 300U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100U/mL in type 1 diabetes. Diabetes Metab. 2018 Feb; 44(1):15-21. Bailey TS, Pettus J, Roussel R, Schmider W, Maroccia M, Nassr N, Klein O, Bolli GB, Dahmen R. PMID: 29153485.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    54. Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice. Curr Med Res Opin. 2017 10; 33(10):1821-1831. Goldman J, Kapitza C, Pettus J, Heise T. PMID: 28537449.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    55. Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting β-hydroxybutyrate levels in a phase IIa pilot study. Diabetes Obes Metab. 2017 06; 19(6):814-821. Henry RR, Dandona P, Pettus J, Mudaliar S, Xu J, Hansen L. PMID: 28098426.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    56. TIME TO GET SERIOUS ABOUT INSULIN TIMING. Endocr Pract. 2017 04 02; 23(4):503-505. Pettus J. PMID: 28156157.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    57. Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes. Diabetes Obes Metab. 2016 10; 18 Suppl 2:17-24. Mudaliar S, Henry RR, Ciaraldi TP, Armstrong DA, Burke PM, Pettus JH, Garhyan P, Choi SL, Knadler MP, Lam EC, Prince MJ, Bose N, Porksen NK, Sinha VP, Linnebjerg H, Jacober SJ. PMID: 27723226.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    58. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM). J Diabetes Sci Technol. 2016 09; 10(5):1087-93. Pettus J, Edelman SV. PMID: 27044518; PMCID: PMC5032948.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    59. Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes. J Diabetes Sci Technol. 2017 01; 11(1):138-147. Pettus J, Edelman SV. PMID: 27530720; PMCID: PMC5375074.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    60. Unblinded CGM Should Replace Blinded CGM in the Clinical Management of Diabetes. J Diabetes Sci Technol. 2016 05; 10(3):793-8. Ahn D, Pettus J, Edelman S. PMID: 26884422; PMCID: PMC5038541.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    61. Effect of ranolazine on glycaemic control in patients with type 2 diabetes treated with either glimepiride or metformin. Diabetes Obes Metab. 2016 May; 18(5):463-74. Pettus J, McNabb B, Eckel RH, Skyler JS, Dhalla A, Guan S, Jochelson P, Belardinelli L, Henry RH. PMID: 26749407.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    62. Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring. Diabetes Technol Ther. 2016 Feb; 18 Suppl 2:S234-42. Pettus J, Edelman SV. PMID: 26784128; PMCID: PMC4717500.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    63. The past, present, and future of basal insulins. Diabetes Metab Res Rev. 2016 09; 32(6):478-96. Pettus J, Santos Cavaiola T, Tamborlane WV, Edelman S. PMID: 26509843.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    64. HOW PATIENTS WITH TYPE 1 DIABETES TRANSLATE CONTINUOUS GLUCOSE MONITORING DATA INTO DIABETES MANAGEMENT DECISIONS. Endocr Pract. 2015 Jun; 21(6):613-20. Pettus J, Price DA, Edelman SV. PMID: 25716635.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    65. Challenges associated with insulin therapy in type 2 diabetes mellitus. Am J Med. 2014 Oct; 127(10 Suppl):S11-6. Edelman S, Pettus J. PMID: 25282008.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    66. Higher proinflammatory cytokine production and spontaneous activation in some type 1 and type 2 diabetic subjects. Clin Immunol. 2014 Nov; 155(1):27-29. Sarikonda G, Sachithanantham S, Pettus J, Rodriguez-Calvo T, Phatak S, Edelman S, von Herrath M. PMID: 25173803.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    67. Testing versus guessing blood glucose values: impact on self-care behaviors in type 2 diabetes. Curr Med Res Opin. 2014 Sep; 30(9):1795-802. Pettus J, Stenger P, Schachner HC, Dunne N, Parkes JL, Pardo S, Edelman SV. PMID: 24889281.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    68. Basal insulin peglispro demonstrates preferential hepatic versus peripheral action relative to insulin glargine in healthy subjects. Diabetes Care. 2014 Sep; 37(9):2609-15. Henry RR, Mudaliar S, Ciaraldi TP, Armstrong DA, Burke P, Pettus J, Garhyan P, Choi SL, Jacober SJ, Knadler MP, Lam EC, Prince MJ, Bose N, Porksen N, Sinha VP, Linnebjerg H. PMID: 24947791.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    69. CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes. J Autoimmun. 2014 May; 50:77-82. Sarikonda G, Pettus J, Phatak S, Sachithanantham S, Miller JF, Wesley JD, Cadag E, Chae J, Ganesan L, Mallios R, Edelman S, Peters B, von Herrath M. PMID: 24387802.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    70. Temporal intra-individual variation of immunological biomarkers in type 1 diabetes patients: implications for future use in cross-sectional assessment. PLoS One. 2013; 8(11):e79383. Sarikonda G, Pettus J, Sachithanantham S, Phatak S, Miller JF, Ganesan L, Chae J, Mallios R, Edelman S, Peters B, von Herrath M. PMID: 24223938; PMCID: PMC3817042.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    71. Keeping the patient perspective: Where are we in the world of type 1 diabetes? Clin Immunol. 2013 Dec; 149(3):265-7. Pettus J, von Herrath M. PMID: 24012473.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    72. GLP-1 agonists in type 1 diabetes. Clin Immunol. 2013 Dec; 149(3):317-23. Pettus J, Hirsch I, Edelman S. PMID: 23643354.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    Jeremy's Networks
    Concepts (200)
    Derived automatically from this person's publications.
    _
    Co-Authors (15)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _